Sarah B
Efstratiadis G, Tsiaousis G, Athyros VG, Karagianni D, Pavlitou-Tsiontsi A, Giannakou-Darda A, Manes C: Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes
This does not establish BPC-157 as an FDA-approved ulcerative colitis treatment or validate every claim made about tendon, ligament, joint, or gastrointestinal healing
While certainly not outweighing the good these medications offer, prescribing physicians need to keep in mind the real and serious ocular adverse events that may occur. 2
Report persistent, worsening or concerning reactions promptly
Call (513) 559-1222 or schedule a free consultation online at JourneyLite.com